Why Wall Street is unfazed by Medicare drug pricing threat
Wall Street concerns over the Inflation Reduction Act pricing negotiations for the first 10 drugs under Medicare's Part D plan appear to be waning.Big Pharma executives have sent signals that they can manage the final reduced prices set by the...

















